These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8569415)

  • 1. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis.
    Santucci V; Storme JJ; Soubrié P; Le Fur G
    Life Sci; 1996; 58(6):PL103-10. PubMed ID: 8569415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats.
    Costa B; Vailati S; Colleoni M
    Behav Pharmacol; 1999 May; 10(3):327-31. PubMed ID: 10780247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.
    Rinaldi-Carmona M; Pialot F; Congy C; Redon E; Barth F; Bachy A; Brelière JC; Soubrié P; Le Fur G
    Life Sci; 1996; 58(15):1239-47. PubMed ID: 8614277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.
    Gueudet C; Santucci V; Rinaldi-Carmona M; Soubrié P; Le Fur G
    Neuroreport; 1995 Jul; 6(10):1421-5. PubMed ID: 7488739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.
    Navarro M; Hernández E; Muñoz RM; del Arco I; Villanúa MA; Carrera MR; Rodríguez de Fonseca F
    Neuroreport; 1997 Jan; 8(2):491-6. PubMed ID: 9080435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine.
    Masserano JM; Karoum F; Wyatt RJ
    Behav Pharmacol; 1999 Jul; 10(4):429-32. PubMed ID: 10780811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive effect of 5-HT2C and CB1 receptor blockade on the regulation of sleep-wake cycle.
    Bogáthy E; Papp N; Tóthfalusi L; Vas S; Bagdy G
    BMC Neurosci; 2019 Mar; 20(1):14. PubMed ID: 30894126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB; Compton DR; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.
    Aceto MD; Scates SM; Lowe JA; Martin BR
    Eur J Pharmacol; 1995 Aug; 282(1-3):R1-2. PubMed ID: 7498260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study.
    Bass CE; Griffin G; Grier M; Mahadevan A; Razdan RK; Martin BR
    Pharmacol Biochem Behav; 2002 Dec; 74(1):31-40. PubMed ID: 12376150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist.
    Mendelson WB; Basile AS
    Neuroreport; 1999 Oct; 10(15):3237-9. PubMed ID: 10574567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cannabinoid CB1 receptor antagonist SR 141716A induces penile erection by increasing extra-cellular glutamic acid in the paraventricular nucleus of male rats.
    Succu S; Mascia MS; Sanna F; Melis T; Argiolas A; Melis MR
    Behav Brain Res; 2006 May; 169(2):274-81. PubMed ID: 16516985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice.
    Darmani NA; Pandya DK
    J Neural Transm (Vienna); 2000; 107(8-9):931-45. PubMed ID: 11041273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analogs of SR-141716A (Rimonabant) alter d-amphetamine-evoked [3H] dopamine overflow from preloaded striatal slices and amphetamine-induced hyperactivity.
    Miller DK; Rodvelt KR; Constales C; Putnam WC
    Life Sci; 2007 Jun; 81(1):63-71. PubMed ID: 17532007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
    Martin RS; Secchi RL; Sung E; Lemaire M; Bonhaus DW; Hedley LR; Lowe DA
    Psychopharmacology (Berl); 2003 Jan; 165(2):128-35. PubMed ID: 12404071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor.
    Murillo-Rodríguez E; Cabeza R; Méndez-Díaz M; Navarro L; Prospéro-García O
    Neuroreport; 2001 Jul; 12(10):2131-6. PubMed ID: 11447321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.
    Richardson JD; Aanonsen L; Hargreaves KM
    Eur J Pharmacol; 1997 Jan; 319(2-3):R3-4. PubMed ID: 9042616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.
    Arnone M; Maruani J; Chaperon F; Thiébot MH; Poncelet M; Soubrié P; Le Fur G
    Psychopharmacology (Berl); 1997 Jul; 132(1):104-6. PubMed ID: 9272766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.